US Stock MarketDetailed Quotes

Phio Pharmaceuticals (PHIO)

Watchlist
  • 1.070
  • -0.050-4.46%
Close May 15 16:00 ET
  • 1.070
  • 0.0000.00%
Post 17:13 ET
12.43MMarket Cap-0.78P/E (TTM)

Phio Pharmaceuticals (PHIO) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
28.26%17.03M
290.77%21.03M
290.77%21.03M
98.61%10.71M
129.35%10.78M
105.07%13.28M
-36.61%5.38M
-36.61%5.38M
-35.89%5.39M
-58.45%4.7M
-Cash and cash equivalents
28.26%17.03M
290.77%21.03M
290.77%21.03M
98.61%10.71M
129.35%10.78M
105.07%13.28M
-36.61%5.38M
-36.61%5.38M
-35.89%5.39M
-58.45%4.7M
Other current assets
134.81%371K
25.71%445K
25.71%445K
66.24%788K
-12.63%519K
-57.64%158K
-57.45%354K
-57.45%354K
-45.58%474K
-12.39%594K
Total current assets
29.52%17.4M
274.41%21.48M
274.41%21.48M
95.99%11.49M
113.42%11.29M
96.20%13.44M
-38.47%5.74M
-38.47%5.74M
-37.14%5.86M
-56.03%5.29M
Non current assets
Net PPE
150.00%10K
450.00%11K
450.00%11K
1,100.00%12K
600.00%7K
100.00%4K
-94.87%2K
-94.87%2K
-99.52%1K
-99.61%1K
-Gross PPE
--10K
-22.40%239K
-22.40%239K
----
----
----
-73.79%308K
-73.79%308K
-99.52%1K
-99.61%1K
-Accumulated depreciation
----
25.49%-228K
25.49%-228K
----
----
----
73.06%-306K
73.06%-306K
----
----
Other non current assets
----
----
----
----
----
----
----
----
----
-50.00%3K
Total non current assets
150.00%10K
450.00%11K
450.00%11K
1,100.00%12K
75.00%7K
-20.00%4K
-95.24%2K
-95.24%2K
-99.53%1K
-98.47%4K
Total assets
29.55%17.41M
274.47%21.49M
274.47%21.49M
96.16%11.51M
113.39%11.3M
96.12%13.44M
-38.72%5.74M
-38.72%5.74M
-38.52%5.87M
-56.93%5.3M
Liabilities
Current liabilities
Payables
-39.11%260K
71.94%435K
71.94%435K
180.43%516K
-29.85%235K
33.44%427K
-61.49%253K
-61.49%253K
6.36%184K
-47.74%335K
-accounts payable
-39.11%260K
71.94%435K
71.94%435K
180.43%516K
-29.85%235K
33.44%427K
-61.49%253K
-61.49%253K
6.36%184K
-47.74%335K
Current accrued expenses
-18.15%690K
18.77%905K
18.77%905K
-0.41%732K
-18.27%971K
-9.26%843K
5.83%762K
5.83%762K
-64.71%735K
-27.87%1.19M
-Current capital lease obligation
----
----
----
----
----
----
--0
--0
--0
--0
Current liabilities
-25.20%950K
32.02%1.34M
32.02%1.34M
81.28%1.67M
-20.81%1.21M
1.68%1.27M
-37.88%1.02M
-37.88%1.02M
-60.49%919K
-36.33%1.52M
Non current liabilities
Preferred securities outside stock equity
--0
--0
--0
----
----
----
--0
--0
----
----
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-25.20%950K
32.02%1.34M
32.02%1.34M
81.28%1.67M
-20.81%1.21M
1.68%1.27M
-37.88%1.02M
-37.88%1.02M
-60.49%919K
-36.33%1.52M
Shareholders'equity
Share capital
--1K
--1K
--1K
--1K
--0
--0
--0
--0
--0
--0
-common stock
--1K
--1K
--1K
--1K
--0
--0
--0
--0
--0
--0
-Preferred stock
----
----
----
--0
--0
--0
----
----
--0
--0
Retained earnings
-7.38%-159.06M
-5.94%-155.05M
-5.94%-155.05M
-5.50%-152.68M
-4.95%-150.29M
-4.79%-148.13M
-5.14%-146.36M
-5.14%-146.36M
-5.40%-144.73M
-6.45%-143.21M
Paid-in capital
9.50%175.52M
15.97%175.2M
15.97%175.2M
8.58%162.52M
9.12%160.39M
9.07%160.3M
2.82%151.08M
2.82%151.08M
3.56%149.68M
1.76%146.98M
Total stockholders'equity
35.27%16.46M
326.57%20.15M
326.57%20.15M
98.93%9.84M
167.56%10.1M
117.17%12.17M
-38.90%4.72M
-38.90%4.72M
-31.43%4.95M
-61.90%3.77M
Total equity
35.27%16.46M
326.57%20.15M
326.57%20.15M
98.93%9.84M
167.56%10.1M
117.17%12.17M
-38.90%4.72M
-38.90%4.72M
-31.43%4.95M
-61.90%3.77M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 28.26%17.03M290.77%21.03M290.77%21.03M98.61%10.71M129.35%10.78M105.07%13.28M-36.61%5.38M-36.61%5.38M-35.89%5.39M-58.45%4.7M
-Cash and cash equivalents 28.26%17.03M290.77%21.03M290.77%21.03M98.61%10.71M129.35%10.78M105.07%13.28M-36.61%5.38M-36.61%5.38M-35.89%5.39M-58.45%4.7M
Other current assets 134.81%371K25.71%445K25.71%445K66.24%788K-12.63%519K-57.64%158K-57.45%354K-57.45%354K-45.58%474K-12.39%594K
Total current assets 29.52%17.4M274.41%21.48M274.41%21.48M95.99%11.49M113.42%11.29M96.20%13.44M-38.47%5.74M-38.47%5.74M-37.14%5.86M-56.03%5.29M
Non current assets
Net PPE 150.00%10K450.00%11K450.00%11K1,100.00%12K600.00%7K100.00%4K-94.87%2K-94.87%2K-99.52%1K-99.61%1K
-Gross PPE --10K-22.40%239K-22.40%239K-------------73.79%308K-73.79%308K-99.52%1K-99.61%1K
-Accumulated depreciation ----25.49%-228K25.49%-228K------------73.06%-306K73.06%-306K--------
Other non current assets -------------------------------------50.00%3K
Total non current assets 150.00%10K450.00%11K450.00%11K1,100.00%12K75.00%7K-20.00%4K-95.24%2K-95.24%2K-99.53%1K-98.47%4K
Total assets 29.55%17.41M274.47%21.49M274.47%21.49M96.16%11.51M113.39%11.3M96.12%13.44M-38.72%5.74M-38.72%5.74M-38.52%5.87M-56.93%5.3M
Liabilities
Current liabilities
Payables -39.11%260K71.94%435K71.94%435K180.43%516K-29.85%235K33.44%427K-61.49%253K-61.49%253K6.36%184K-47.74%335K
-accounts payable -39.11%260K71.94%435K71.94%435K180.43%516K-29.85%235K33.44%427K-61.49%253K-61.49%253K6.36%184K-47.74%335K
Current accrued expenses -18.15%690K18.77%905K18.77%905K-0.41%732K-18.27%971K-9.26%843K5.83%762K5.83%762K-64.71%735K-27.87%1.19M
-Current capital lease obligation --------------------------0--0--0--0
Current liabilities -25.20%950K32.02%1.34M32.02%1.34M81.28%1.67M-20.81%1.21M1.68%1.27M-37.88%1.02M-37.88%1.02M-60.49%919K-36.33%1.52M
Non current liabilities
Preferred securities outside stock equity --0--0--0--------------0--0--------
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -25.20%950K32.02%1.34M32.02%1.34M81.28%1.67M-20.81%1.21M1.68%1.27M-37.88%1.02M-37.88%1.02M-60.49%919K-36.33%1.52M
Shareholders'equity
Share capital --1K--1K--1K--1K--0--0--0--0--0--0
-common stock --1K--1K--1K--1K--0--0--0--0--0--0
-Preferred stock --------------0--0--0----------0--0
Retained earnings -7.38%-159.06M-5.94%-155.05M-5.94%-155.05M-5.50%-152.68M-4.95%-150.29M-4.79%-148.13M-5.14%-146.36M-5.14%-146.36M-5.40%-144.73M-6.45%-143.21M
Paid-in capital 9.50%175.52M15.97%175.2M15.97%175.2M8.58%162.52M9.12%160.39M9.07%160.3M2.82%151.08M2.82%151.08M3.56%149.68M1.76%146.98M
Total stockholders'equity 35.27%16.46M326.57%20.15M326.57%20.15M98.93%9.84M167.56%10.1M117.17%12.17M-38.90%4.72M-38.90%4.72M-31.43%4.95M-61.90%3.77M
Total equity 35.27%16.46M326.57%20.15M326.57%20.15M98.93%9.84M167.56%10.1M117.17%12.17M-38.90%4.72M-38.90%4.72M-31.43%4.95M-61.90%3.77M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More